PMC:7558914 / 818-1168
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
39 | 82-90 | Species | denotes | patients | Tax:9606 |
46 | 1-20 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
47 | 172-190 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
48 | 196-208 | Chemical | denotes | azithromycin | MESH:D017963 |
49 | 220-238 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
50 | 244-263 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
51 | 299-317 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
52 | 322-341 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
67 | 114-124 | Disease | denotes | pneumonias | MESH:D011014 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T2 | 114-124 | Phenotype | denotes | pneumonias | http://purl.obolibrary.org/obo/HP_0002090 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T9 | 52-272 | Sentence | denotes | The recommended treatment for patients with mild and moderate pneumonias was different antiviral combinations including hydroxychloroquine plus azithromycin (93.3%) or hydroxychloroquine plus lopinavir/ritonavir (79.9%). |